Westerkirk Capital Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 2080423 VICTORIA, A1

Position in GILD

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$3,245,169

+$2,522,397 QoQ

Shares Held

25,686

+395.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.46%

of 13F equity value

Holder Rank

#693

of 2,266 holders

Holding Since

Jun 2025

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Westerkirk Capital Inc. holds $40,505,317 across 6 Drug Manufacturers - General names. GILD ranks #5 (8.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	13,207	$15,840,873
2	JNJ	Johnson & Johnson	38,959	$9,894,417
3	MRK	Merck & Co., Inc.	46,500	$5,975,250
4	AZN	Astrazeneca PLC	28,729	$5,447,592
5	GILD	Gilead Sciences, Inc. This page	25,686	$3,245,169
6	NVO	Novo Nordisk A S	2,128	$102,016

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,245,169	25,686	+395.3%	Shares	Sole	2026-08-10
2026-03-31	$722,772	5,186	0.0%	Shares	Sole	2026-05-14
2025-12-31	$636,529	5,186	-7.6%	Shares	Sole	2026-02-11
2025-09-30	$622,821	5,611	0.0%	Shares	Sole	2025-11-10
2025-06-30	$622,091	5,611	—	Shares	Sole	2025-08-13
No filing history on record for this holder in this stock.